CI Stock Recent News
CI LATEST HEADLINES
Analysts expect the company to report earnings of $7.23 per share for the third quarter and sales of $59.6 billion.
CI's Q3 results are likely to be aided by strength in the specialty pharmacy business, partly offset by elevated medical costs resulting from higher utilization trends.
There has been speculation of a massive merger in the medical sector between two massive health insurers. Specifically, the rumor is The Cigna Group NYSE: CI is interested in acquiring Humana Inc. NYSE: HUM.
Get a deeper insight into the potential performance of Cigna (CI) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
NEW YORK--(BUSINESS WIRE)--The Center's Women's Event honors Keia Clarke and Dr. Renee Mclaughlin for LGBTQ+ advocacy in sports and healthcare, Sydnee Washington to host.
BLOOMFIELD, Conn. , Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024.
A media report stated that the company is determined to grow with a major merger deal.
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
Humana (HUM) shares edged higher Monday morning on a report that The Cigna Group (CI) has resumed discussions to buy its smaller health insurance rival after negotiations fell apart last year. Cigna shares declined.
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.